ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $77,292 | -3.0% | 21,590 | 0.0% | 0.00% | – |
Q2 2023 | $79,667 | +24.5% | 21,590 | +11.4% | 0.00% | – |
Q1 2023 | $64,000 | +30.6% | 19,373 | +51.0% | 0.00% | – |
Q4 2022 | $49,000 | -14.0% | 12,829 | -55.5% | 0.00% | – |
Q2 2022 | $57,000 | +9.6% | 28,833 | 0.0% | 0.00% | – |
Q1 2022 | $52,000 | +116.7% | 28,833 | +55.4% | 0.00% | – |
Q4 2021 | $24,000 | +20.0% | 18,552 | 0.0% | 0.00% | – |
Q3 2021 | $20,000 | -31.0% | 18,552 | 0.0% | 0.00% | – |
Q2 2021 | $29,000 | -12.1% | 18,552 | 0.0% | 0.00% | – |
Q1 2021 | $33,000 | +6.5% | 18,552 | +14.2% | 0.00% | – |
Q4 2020 | $31,000 | +40.9% | 16,242 | +55.4% | 0.00% | – |
Q3 2020 | $22,000 | – | 10,452 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |